PMG Research of Knoxville — Oak Ridge, Tennessee

PMG Research of Knoxville is a clinical research site located in Oak Ridge, Tennessee, United States 37830.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

PMG Research of Knoxville has participated in 1 clinical trials.

Therapeutic areas: Hot Flashes.

Sponsors: Fervent Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oak Ridge

Browse all research sites in Tennessee · View every site in Oak Ridge

• Covenant Health Oncology Group - Oak Ridge
• Research Site
• Thompson Oncology Group-Oak Ridge
• Parkway Cardiology Associates
• Methodist Medical Center
• Parkway Cardiology Associates PC
• Thompson Cancer Survival Center at Methodist
• Novartis Investigative Site
• GSK Investigational Site
• Covenant Medical Group d/b/a Parkway Cardiology Associates
• Investigational Site Number 840072

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for PMG Research of Knoxville?

PMG Research of Knoxville has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has PMG Research of Knoxville conducted?

PMG Research of Knoxville has 1 clinical trials on record. Their work covers Hot Flashes.

Is PMG Research of Knoxville accredited by Crixeo Clinical Trials?

PMG Research of Knoxville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about PMG Research of Knoxville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.